June 26, 2025

Recalling Daily Events Improves Morning Memory

A behavioral task asking older adults to recall daily events before sleep was linked to better memory recognition the next morning, showing potential as a low-risk strategy to support cognitive health in aging and early Alzheimer’s disease.

Conexiant

June 25, 2025

Blood Marker May Predict Faster Brain Decline

A new study found that higher triglyceride-glucose index levels, a marker of insulin resistance, were linked to faster cognitive decline in early Alzheimer's, suggesting potential for improved risk assessment in clinical settings.

Conexiant

June 25, 2025

Nighttime Heart Rhythms Predict Brain Disorders

A large Swiss study found that nighttime heart rate patterns may predict future risk for brain and psychiatric disorders, while traditional sleep structure measures were less informative.

Conexiant

June 23, 2025

STING Deletion Attenuates Amyloid Beta Pathology

Genetic deletion of STING in a mouse model of Alzheimer’s disease reduced amyloid plaque accumulation, suppressed neuroinflammatory responses, and improved memory, highlighting STING’s role in disease progression and potential as a therapeutic target.

Conexiant

June 23, 2025

Sitting-Rising Test Predicts Long-Term Mortality Risk

A 12-year study of over 4,000 adults found that poor performance on a basic sitting and rising test was strongly linked to increased risk of death from natural and cardiovascular causes.

Conexiant

June 20, 2025

Does Breast Cancer Lower Alzheimer Risk?

Large Korean cohort study finds breast cancer survivors have an 8% lower Alzheimer disease risk, with radiation therapy showing protective effects.

Conexiant

June 20, 2025

Retinal Changes Linked to Neurological Disease Progression

New research reviewed dozens of studies and revealed that visual dysfunction, including retinal changes, may serve as early signs of neurodegenerative and neurodevelopmental diseases, offering a noninvasive pathway for earlier diagnosis and disease monitoring.

Conexiant

June 19, 2025

Single Psilocybin Dose Yields Long-Term Cancer Relief

A single psilocybin dose combined with therapy led to lasting reductions in depression and anxiety for cancer patients two years after treatment, according to new research.

Conexiant

June 18, 2025

Rethinking “Asymptomatic” in Brain Autopsies

Unexpected changes in “control” brains calls attention to underrepresentation in Alzheimer's research

The Pathologist